BOSTON — In this Healio Video Perspective from the ASCRS meeting, Abu Abraham, MD, of Cloudbreak Pharma, and John A. Hovanesian, MD, FACS, discuss developments in the treatment of pterygium. Abraham previews an eye drop solution, currently in a phase 3 clinical trial, designed to treat pterygium through twice-daily dosing. “The good news for us is that...

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Brett H. Mueller II, DO, PhD, ABO, discusses how adopting the EVO ICL into his practice has benefited him and his patients. The EVO ICL (STAAR Surgical) offers patients an alternative to the permanence of LASIK and differentiates Mueller’s practice from other practices, he said. “When...

Researchers reported an association between the severity of internal carotid artery stenosis and retinal health in proliferative diabetic retinopathy, highlighting the importance of carotid artery evaluations in these patients. “Proliferative diabetic retinopathy (PDR) and internal carotid artery (ICA) stenosis are interconnected conditions with implications...

Ocugen has announced that dosing is complete in the second cohort of its phase 1/2 ArMaDa clinical trial to assess the safety of OCU410, a modifier gene therapy candidate for geographic atrophy. “We are very enthusiastic about the potential of OCU410 as a one-time, gene-agnostic option for the treatment of GA,” Huma Qamar, MD, MPH, Ocugen’s chief medical...

RevOpsis Therapeutics closed its first seed funding round and raised $16.5 million to advance RO-104, its lead candidate for the treatment of neovascular age-related macular degeneration. The funding includes $7.5 million in non-dilutive capital, according to a press release, and will be used to complete the investigational new drug-enabling studies...

Smartphone viewing distance was similar among children with and without myopia, with researchers reporting that 60% of variance was attributable to individual differences, according to a study in Ophthalmic and Physiological Optics. “A prominent hypothesis attributes the onset and progression of myopia to sustained near viewing, which for many children...